PriceTargets.com logo

Quantum Genomics Société Anonyme - QNNTF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.10 As of 01/16/2025 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for QNNTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Quantum Genomics Société Anonyme Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for QNNTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for QNNTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Quantum Genomics Société Anonyme in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.10.

This chart shows the closing price for QNNTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Quantum Genomics Société Anonyme. This rating has held steady since October 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/31/2022CheuvreuxDowngradeBuy ➝ Hold
(Data available from 1/17/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/17/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Quantum Genomics Société Anonyme logo
Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.
Read More

Today's Range

Now: $0.10
Low: $0.10
High: $0.10

50 Day Range

MA: $0.10
Low: $0.10
High: $0.10

52 Week Range

Now: $0.10
Low: $0.10
High: $0.10

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22

Frequently Asked Questions

What sell-side analysts currently cover shares of Quantum Genomics Société Anonyme?

The following Wall Street sell-side analysts have issued reports on Quantum Genomics Société Anonyme in the last year:
View the latest analyst ratings for QNNTF.

What is the current price target for Quantum Genomics Société Anonyme?

0 Wall Street analysts have set twelve-month price targets for Quantum Genomics Société Anonyme in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Quantum Genomics Société Anonyme in the next year.
View the latest price targets for QNNTF.

What is the current consensus analyst rating for Quantum Genomics Société Anonyme?

Quantum Genomics Société Anonyme currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for QNNTF.

What other companies compete with Quantum Genomics Société Anonyme?

Other companies that are similar to Quantum Genomics Société Anonyme include Advanced Life Sciences, AVAX Technologies, Clarus Therapeutics, Eloxx Pharmaceuticals and Gene Biotherapeutics. Learn More about companies similar to Quantum Genomics Société Anonyme.

How do I contact Quantum Genomics Société Anonyme's investor relations team?

Quantum Genomics Société Anonyme's physical mailing address is 33 Rue Marbeuf, Paris I0, 75008. The company's listed phone number is 33-01-85-34-77-70. The official website for Quantum Genomics Société Anonyme is www.quantum-genomics.com. Learn More about contacing Quantum Genomics Société Anonyme investor relations.